drugset / Trial / NCT00503217
GnRH Agonist and Intrauterine Insemination
RandomizedParallel-groupSingle-blind
Summary
The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.
Timeline
- Start
- 2005-02
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | — | — |
Indications
No indication recorded.